Background:
Cryptococcus neoformans are basidiomycetous; encapsulated yeasts
are classified into 4 serotypes according to their capsule. (1) the way
of the infection is by inhalation of basidiospore form or small, poorly
encapsulated yeasts. (2) Cryptococcus neoformans infection
typically happens among immunocompromised patients and
meningoencephalitis is the typical manifestation of cryptococcosis among
HIV patients. (3, 4) in immunocompetent, the infection can be
subclinical and a study on postmortem immunocompetent just showed small
granulomatous disease in the lung without disseminating the infection.
(5, 6) We describe a case of a patient with COVID-19 who developed
Cryptococcemia while being treated by immunosuppressive treatment.